Murphy & Mullick Capital Management’s Eli Lilly LLY Stock Holding History

Murphy & Mullick Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.29M	Buy	1,406 +4	+0.3%	+$4.05K	0.96%	26
2025 Q4	$1.51M	Sell	1,402 -61	-4%	-$58.3K	1.09%	20
2025 Q3	$1.13M	Sell	1,463 -50	-3%	-$37.2K	0.84%	26
2025 Q2	$1.12M	Buy	1,513 +1	+0.1%	+$777	0.91%	26
2025 Q1	$1.25M	Sell	1,512 -125	-8%	-$104K	1.21%	19
2024 Q4	$1.26M	Buy	+1,637	New	+$1.36M	1.16%	19

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Murphy & Mullick Capital Management's LLY Position: Q1 2026 in Review

Murphy & Mullick Capital Management increased its Eli Lilly (LLY) stake by 0.29% in Q1 2026, buying an estimated $4.05K and bringing the position to 1,406 shares worth $1.29M. The position accounts for 0.96% of the portfolio, ranked #26.

Murphy & Mullick Capital Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.51M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Murphy & Mullick Capital Management held 1,406 shares of Eli Lilly worth $1.29M as of Q1 2026.
Murphy & Mullick Capital Management bought 4 Eli Lilly shares in Q1 2026, an estimated $4.05K.
Eli Lilly made up 0.96% of Murphy & Mullick Capital Management's portfolio in Q1 2026, its #26 holding.
Murphy & Mullick Capital Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
Murphy & Mullick Capital Management's Eli Lilly position peaked at $1.51M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.